International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, Adult and Pediatric Units, Device-associated Module

Rosenthal, Victor; Duszyńska, Wiesława; Bat-Erdene, Ider; Gurskis, Vaidotas; Al-Ruzzieh, Majeda A; Myatra, Sheila Nainan; Gupta, Debkishore; Belkebir, Souad; Upadhyay, Namita; Zand, Farid; Todi, Subhash; Kharbanda, Mohit; Nair, Pravin K; Mishra, Sanghamitra; Chaparro, Gustavo Jorge; Mehta, Yatin; Zala, Dolatsinh; Janc, Jarosław; Aguirre-Ávalos, Guadalupe; Aguilar-de-Moros, Daisy; Hernandez-Chena, Blanca Estela; Gün, Emrah; Oztoprak-Cuvalci, Nefise; Yıldızdaş, Dinçer; Abdelhalim, Mona Moheyeldin; Deniz, Seçil; Gan, Chin Seng; Hùng, Nguyễn Việt; Joudi, Hala; Omar, Abeer; Gikas, Achilleas; El-Kholy, Amani; Barkat, Amina; Koirala, Anjeela; Cerero-Gudiño, Antonio; Bouziri, Asma; Gomez-Nieto, Katherine; Fisher, Dale; Medeiros, Eduardo Alexandrino Sérvolo de; Salgado-Yepez, Estuardo; Horhat, Florin George; Agha, Hala Mounir; Vimercati, Julio César; Villanueva, Victoria; Jayatilleke, Kushlani; Nguyet, Le Thi Thu; Raka, Lul; Miranda-Novales, María Guadalupe; Petrov, Michael M.; Apisarnthanarak, Anucha; Tayyab, Nadia; Elahi, Naheed; Mejía, Nepomuceno; Morfín‐Otero, Rayo; Al-Khawaja, Safa; Anguseva, Tanja; Gupta, Umesh Datta; Бельский, В. А.; Mat, Wan Rahiza Wan; Chapeta-Parada, Edwin Giovanny; Garcell, Humberto Guanche; Barahona-Guzmán, Nayide; Mathew, Anju Chempakasseril; Raja, Kavita; Pattnaik, Saroj Kumar; Pandya, Nirav; Poojary, Aruna; Chawla, Rajesh; Mahfouz, Tahsine; Kanj, Souha S.; Mioljević, Vesna; Hlinková, Soňa; Mrazova, M.; Al-Abdely, Hail M.; Güçlü, Ertuğrul; Özgültekin, Asu; Baytaş, Volkan; Tekin, Recep; Yalcin, Ata Nevzat; Erben, Nurettin

doi:10.1016/j.ajic.2021.04.077

Cited by 65 publications

(41 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The resistance rates of HAIs to the majority of antibiotics that are currently approved for empiric, but also targeted therapy in our country are extremely high. Compared to all EU/EEA countries and international reports, our findings show much higher resistance rates, with only Romania and Greece reporting somewhat comparable results for certain antimicrobial groups [1,21]. Furthermore, our results are consistent with the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) reports from our country, where resistance to pathogens such as A. baumannii exceeds 90% for all tested antibiotics [22].…”

Section: Discussionsupporting

confidence: 90%

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units

et al. 2021

View full text Add to dashboard Cite

Hospital-acquired infections (HAIs) are a global public health concern. As the COVID-19 pandemic continues, its contribution to mortality and antimicrobial resistance (AMR) grows, particularly in intensive care units (ICUs). A two-year retrospective study from April 2019–April 2021 was conducted in an adult ICU at the Hospital for Infectious and Tropical Diseases, Belgrade, Serbia to assess causative agents of HAIs and AMR rates, with the COVID-19 pandemic ensuing halfway through the study. Resistance rates >80% were observed for the majority of tested antimicrobials. In COVID-19 patients, Acinetobacter spp. was the dominant cause of HAIs and more frequently isolated than in non-COVID-19 patients. (67 vs. 18, p = 0.001). Also, resistance was higher for imipenem (56.8% vs. 24.5%, p < 0.001), meropenem (61.1% vs. 24.3%, p < 0.001) and ciprofloxacin (59.5% vs. 36.9%, p = 0.04). AMR rates were aggregated with findings from our previous study to identify resistance trends and establish empiric treatment recommendations. The increased presence of Acinetobacter spp. and a positive trend in Klebsiella spp. resistance to fluoroquinolones (R2 = 0.980, p = 0.01) and carbapenems (R2 = 0.963, p = 0.02) could have contributed to alarming resistance rates across bloodstream infections (BSIs), pneumonia (PN), and urinary tract infections (UTIs). Exceptions were vancomycin (16.0%) and linezolid (2.6%) in BSIs; tigecycline (14.3%) and colistin (0%) in PNs; and colistin (12.0%) and linezolid (0%) in UTIs. COVID-19 has changed the landscape of HAIs in our ICUs. Approval of new drugs and rigorous surveillance is urgently needed.

show abstract

Section: Discussionsupporting

confidence: 90%

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units

et al. 2021

View full text Add to dashboard Cite

show abstract

“…9 CAUTI rates in neurologic and neurosurgical ICUs through INICC reports from 45 countries between 2012 and 2017 was 6.0 and 4.6 infections per 1000 catheter days, 10 and in the latest summary from 2013 to 2018 was 4.7 and 4.6 infections per 1000 catheter days. 11 As is evident in Table 1, studies with higher rates of device utilization ratio (DUR) have reported higher rates of CAUTI. Notably, a very dramatic increase in CAUTI rate might be seen when DUR exceeds .85 compared to DUR <.5.…”

Section: Cauti Epidemiologymentioning

confidence: 98%

“…6 Compared to NHSN records from healthcare facilities in the United States, higher rates of CAUTI were reported in International Nosocomial Infection Control Consortium (INICC) reports. [9][10][11] The rate of CAUTI in neurologic and neurosurgical ICUs in INICC reports from 50 countries between 2010 and 2015 was 17.2 and 6.2 infections per 1000 catheter days. 9 CAUTI rates in neurologic and neurosurgical ICUs through INICC reports from 45 countries between 2012 and 2017 was 6.0 and 4.6 infections per 1000 catheter days, 10 and in the latest summary from 2013 to 2018 was 4.7 and 4.6 infections per 1000 catheter days.…”

Section: Cauti Epidemiologymentioning

confidence: 99%

Catheter-Associated Urinary Tract Infection in Neurological Intensive Care Units: A Narrative Review

Firoozeh

Agah

Bauer

et al. 2022

The Neurohospitalist

View full text Add to dashboard Cite

Catheter-associated urinary tract infection (CAUTI) is among the most common types of healthcare-associated infection (HAI), which is associated with poor outcomes and prolonged hospitalization in critically ill patients. Previous studies have mentioned that patients admitted to neurological ICUs are at higher risk of CAUTI compared to patients in other ICU settings. This review paper aims to review studies published during the last decade that evaluated the incidence, risk factors, causative pathogens, and preventive strategies and treatment in neuro-critically ill patients.

show abstract

“…Figure 2 shows part of the International Nosocomial Infection Control Consortium (INICC) data from device-associated infection (Nicolle, 2014). This report highlights the importance of catheter-associated UTI, with 30.15% of fatalities among 1,844 patients hospitalized in 45 countries (Rosenthal et al, 2021). UTIs have a bimodal onset age, with one peak occurring in the first year of life and another peak occurring between 2 and 4, which correlates to toilet training (Korbel et al, 2017).…”

Section: Uti Is a Prevalent And Costly Public Health Concernmentioning

confidence: 99%

Infecção do trato urinário causada por Escherichia coli uropatogênica resistente a antibióticos: um importante problema de saúde pública

Goulart

2021

RSD

View full text Add to dashboard Cite

Urinary tract infection (UTI) caused by uropathogenic Escherichia coli (UPEC) is one of the most prevalent bacterial infections and is a major cause of health-related morbidity and hospital costs worldwide. The rising bacterial resistance to routinely given antibiotics for infected individuals is becoming a significant source of concern. Current research shows that UPEC is becoming more resistant to multiple antibiotic classes, including fluoroquinolones, beta-lactams, and aminoglycosides, as a result of genetic determinants of resistance and multidrug-resistant clones. Knowledge of the local etiology and the sensitivity profile of the most common uropathogens to antibiotics should guide decisions in the empirical therapy of uncomplicated UTI. Given the high prevalence of UTI and multidrug-resistant bacteria, preventative measures such as the development of an efficient vaccination are essential. The current work is an integrated literature review that synthesizes information on UTIs caused by antibiotic-resistant uropathogenic E. coli and considers the practical implications of key research results.

show abstract

International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2013-2018, Adult and Pediatric Units, Device-associated Module

Cited by 65 publications

References 34 publications

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units

Catheter-Associated Urinary Tract Infection in Neurological Intensive Care Units: A Narrative Review

Infecção do trato urinário causada por Escherichia coli uropatogênica resistente a antibióticos: um importante problema de saúde pública

Contact Info

Product

Resources

About